Bladder cancer trail: DNA in blood and urine may predict treatment success
NCT ID NCT05630131
First seen Dec 10, 2025 · Last updated May 20, 2026 · Updated 19 times
Summary
This small pilot study looked at whether DNA from cancer cells (called ctDNA) can be detected in the blood or urine of people with muscle-invasive bladder cancer who are receiving a combination of surgery, radiation, and chemotherapy. The goal was to see if collecting and measuring ctDNA is practical. If successful, this approach could help doctors monitor how well the treatment is working and predict outcomes. Only one person took part, so the results are very early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
North Carolina Cancer Hospital (UNC)
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.